Advances and Scientific Merits in Biologics and Biosimilars

March 05-07, 2020 | San Francisco, USA



Biologics and Biosimilars Conference 2020

Biosimilars are now booming in the current dispensing industry and currently the biggest driver of pharmaceutical. Developing and exploring the biosimilars product is the major scenario. Biosimilars are ruling materials in the share marketing. Which biosimilar makers must offer payers substantial rebates to gain market share through favored formulary deck placement drives. Endling Scientific Merits planned to organize an international conference on “Advances and Scientific Merits in Biologics & Biosimilars.

The main aim of the conference is to bring research advances aimed at understanding the scout of biosimilars. The global event with a theme “Exploring and broadening the strategies in dispensing pharmacy” brings scientists and researchers from academia and industry together to exchange the research ideas and findings in the field of biosimilars medicine.

SCIENTIFIC SESSIONS

Biologics/ Biosimilars Development

Current Challenges in Developing Biosimiliars

Chemical and Analytical Strategies for Biosimilars

BPCIA and Regulatory Updates

Pharmaceutical Regulatory Affairs and IPR

Intellectual Property Rights for Biosimilars

Formulation Strategies for Follow-on Biologics

Emerging Biosimilars and research pipelines

Biosimilars in Oncology

Biosimilars in Gastroenterology, Rheumatology and Dermatology

Clinical trial development for Biosimilars

Biosimilars Clinical Research and safety

Biosimilars: Pharmacovigilance ( challenges and innovation )

Monoclonal Antibody and Fusion Protein Biosimilars

Biogenerics and Biopharmaceuticals

Biosimilars market and cost analysis

Biologics/Biosimilars as therapeutics

BCS and IVIVC based Biowaivers

Clinical Trials in Biosimilars

Drug Development and Delivery

Pharmaceutical Industry Tussles over Biosimilars

Biosimilars Market and Cost Analysis

Globalization of Biosimilars

USFDA approved Biosimilars

TARGET AUDIENCE

Biologics/Biosimilar Pharmaceutical researchers

Biomedical Product Development and Manufacturers

Regulatory Affairs Professionals

Clinical and Nonclinical Research persons

Biostatistics and Data Management experts

Business Development Executives

Marketing and Commercialization Staff involved with biosimilars

Medical Communicators

Patient Advocacy/Patient Support Programs

Physicians including specialists across therapeutic disciplines

Pharmacists and pharmacy professionals

Doctors and researchers in medical sciences

Members of Organizing Committee

Dr. Candida Fratazzi

CEO/Founder
Boston Biotech Clinical Research, USA

Dr. Peter Kalinka

Chairman
Longmore 60 Biotech Inc, USA

Dr. Meghana Joshi

Program Director
Biocon-KGI, USA

Dr. Hu Zhang

Professor in Bioprocessing and Biotechnology
KGI, USA

Dr. Abdeen Mustafa Omer

Occupation Health Administration, Ministry of Health
Khartoum, Sudan

Dr. Deepagan Veerasikku Gopal

Research Fellow in Drug Discovery Disposition and Dynamics Theme
Monash University, Australia

Dr. Faizah Safina Bakrin

KPJ Healthcare University College
Malaysia

Dr. Michel Mikhail

Global Expert in Regulatory Affairs
International Expert in Biosimilars
Germany

Dr. MANDLA STANLEY MAKHANYA

University of South Africa
South Africa

LOCATION

San Francisco, USA


+1 612 345 3834 biosimilars.norawest@gmail.com

MEDIA PARTNERS

RECOMMENDED CONFERENCES

copyright © 2019 all rights reserved Onlineesm